Other Information.
−Removed: Certification of Chief Executive Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
−Removed: Certification of Chief Financial Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
−Removed: Certification of Chief Executive Officer and Chief Financial Officer of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
−Removed: Press Release for Quarter Ended June 30, 2020 (filed herewith).
+Added: Certification of Chief Executive Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act
+Added: of 2002 (filed herewith).
+Added: Certification of Chief Financial Officer of the Company in accordance with Section 302 of the Sarbanes-Oxley Act
+Added: of 2002 (filed herewith).
+Added: Certification of Chief Executive Officer and Chief Financial Officer of the Company in accordance with Section 906
+Added: of the Sarbanes-Oxley Act of 2002 (filed herewith).
+Added: Press Release for Quarter Ended September 30, 2020 (filed herewith).
Interactive Data File
2 unchanged sentences
Fennec Pharmaceuticals Inc.
−Removed: August 5, 2020
−Removed: /s/ Rostislav Raykov
+Added: November 16, 2020
+Added: /s/ Rostislav
Rostislav Raykov
1 unchanged sentence
(principal executive officer)
−Removed: August 5, 2020
+Added: November 16, 2020
/s/ Robert Andrade
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.